ABI Solid Sequencing

From WikiMD's Food, Medicine & Wellness Encyclopedia

Library preparation for the SOLiD platform.svg
Two-base encoding scheme.png

ABI Solid Sequencing is a next-generation sequencing (NGS) technology developed by Applied Biosystems, which is now part of Thermo Fisher Scientific. This method is based on sequencing by ligation, a different approach from the more commonly known sequencing by synthesis used in other NGS platforms such as Illumina sequencing and Ion Torrent sequencing. ABI Solid Sequencing was introduced to the market to provide high-throughput sequencing solutions for genomic research.

Overview[edit | edit source]

ABI Solid Sequencing technology utilizes a unique method of DNA sequencing that involves the ligation of fluorescently labeled oligonucleotide probes to DNA templates. This process is cyclic and involves the sequential hybridization of probes, ligation, detection, and cleavage. Each cycle adds a known sequence of bases to the growing DNA strand, allowing for the determination of the DNA sequence based on the color-coded sequence of probes that have been ligated.

Technology[edit | edit source]

The core of ABI Solid Sequencing technology lies in its use of two-base encoding. In this system, each fluorescent dye is associated with a specific pair of bases rather than a single base. This method provides an inherent error-checking mechanism, as each base is read multiple times in different dinucleotide contexts. The sequencing process begins with the attachment of DNA fragments to a solid surface, followed by the ligation of fluorescently labeled probes that correspond to specific dinucleotide sequences. The identity of each probe is determined by its fluorescent label, and the sequence of the template DNA is deduced from the pattern of fluorescence observed over successive cycles of ligation and detection.

Applications[edit | edit source]

ABI Solid Sequencing has been applied in various areas of genomic research, including whole-genome sequencing, transcriptome analysis, and epigenomics. Its high-throughput capability and accuracy make it suitable for large-scale genomic studies. However, the complexity of data analysis and the specific advantages of other sequencing technologies have led to a diversification of sequencing technology choices among researchers.

Advantages and Disadvantages[edit | edit source]

One of the main advantages of ABI Solid Sequencing is its high accuracy, particularly in the context of repetitive sequences, due to the two-base encoding system. This feature reduces the impact of sequencing errors, which are a common challenge in NGS technologies. However, the technology also has its disadvantages, including a relatively complex library preparation and data analysis process. Additionally, the initial cost and operational complexity have limited its adoption compared to other NGS platforms.

Current Status[edit | edit source]

As of the last update, ABI Solid Sequencing technology has seen decreased usage in the face of rapid advancements and the introduction of newer, more efficient sequencing technologies. Thermo Fisher Scientific continues to support genomic research through the development of other sequencing platforms and technologies.

ABI Solid Sequencing Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD